L. Bajzar et al., BOTH CELLULAR AND SOLUBLE FORMS OF THROMBOMODULIN INHIBIT FIBRINOLYSIS BY POTENTIATING THE ACTIVATION OF THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR, The Journal of biological chemistry, 273(5), 1998, pp. 2792-2798
Thrombin-activable fibrinolysis inhibitor (TAFI) is a recently describ
ed plasma zymogen that can be activated by thrombin to an enzyme with
carboxypeptidase B-like activity, The enzyme, TAFIa, potently attentua
tes fibrinolysis, TAFI activation, like protein C activation, is augme
nted about 1250-fold by thrombomodulin (TM), In this work, the effects
of both soluble and cellular forms of TM on TAFI activation-dependent
suppression of fibrinolysis were investigated, Soluble TM included in
clots formed from purified components, barium citrate-adsorbed plasma
, or normal human plasma maximally increased the tissue plasminogen ac
tivator-induced lysis time PS-fold, with saturation occurring at 5, 10
, and 1 nM TM in the three respective systems. Soluble TM did not effe
ct lysis in the system of purified components lacking TAFI or in plasm
as immunodepleted of TAFI, In addition, the antifibrinolytic effect of
TM was negated by monoclonal antibodies against either TAFI or TM, Th
e inhibition of fibrinolysis by cellular TM was assessed by forming cl
ots in dialyzed, barium citrate-adsorbed, or normal plasma over cultur
ed human umbilical vein endothelial cells (HUVECs), Tissue plasminogen
activator-induced lysis time was increased 2-fold, with both plasmas,
in the presence of HUVECs, The antifibrinolytic effect of HUVECs was
abolished 66% by specific anti-TAFI or anti-TM monoclonal antibodies,
A newly developed functional assay demonstrated that HUVECs potentiate
the thrombin-catalyzed. TM-dependent formation of activated TAFI, Thu
s, endothelial cell TRI, in vitro at least, appears to participate in
the regulation of not only coagulation but also fibrinolysis.